Ellington Management Group
SRNE

Ellington Management Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Ellington Management Group’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-12,400
Closed -$64K – 937
2018
Q1 		$64K Buy
+12,400
New +$88.2K ﹤0.01% 787
2016
Q1 		– Sell
-12,652
Closed -$110K – 749
2015
Q4 		$110K Sell
12,652
-6,600
-34% -$55.7K 0.04% 536
2015
Q3 		$162K Buy
19,252
+5,073
+36% +$80.8K 0.05% 613
2015
Q2 		$250K Buy
+14,179
New +$182K 0.06% 503

Other funds holding SRNE

State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
IP
Intellectus Partners San Francisco, California $578M AUM 49.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ellington Management Group's SRNE Position: Q2 2018 in Review

Ellington Management Group sold out of Sorrento Therapeutics, Inc. (SRNE) in Q2 2018, closing a stake of 12,400 shares — an estimated $64K sold.

Ellington Management Group first reported a position in SRNE in Q2 2015 and held it in 4 quarters. The position peaked at $250K in Q2 2015. 94 funds tracked by Wall St. Rank hold SRNE as of Q2 2018.

  • Ellington Management Group reported no remaining Sorrento Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
  • Ellington Management Group sold 12,400 Sorrento Therapeutics, Inc. shares in Q2 2018, an estimated $64K.
  • Ellington Management Group first reported a position in Sorrento Therapeutics, Inc. in Q2 2015 and held it in 4 quarters.
  • Ellington Management Group's Sorrento Therapeutics, Inc. position peaked at $250K in Q2 2015.
  • 94 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2018.

Based on Ellington Management Group's 13F filing for Q2 2018, filed 14 Aug 2018.